| 55153-1 |
Biotinidase panel |
- |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Biotinidase panel - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
55153-1 |
|
|
|
|
Order |
|
|
|
0 |
Biotinidase Pnl SerPl |
|
|
|
N |
|
Biotinidase Pnl; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55154-9 |
Ethambutol+rifAMPin |
Susc |
Isolate |
Pt |
OrdQn |
Method for Slow-growing mycobacteria |
|
ACTIVE |
Ethambutol+rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria |
|
MIN |
DefinitionDescription |
|
|
|
Resistant, Susceptible, Indeterminate |
|
|
|
|
|
ABXBACT |
|
55154-9 |
|
Method for Slow-growing mycobacteria |
|
|
Observation |
|
|
|
0 |
Ethambutol+rifAMPin Islt SlowMyco |
|
|
|
N |
|
AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; Etambol; Ethamb; ID; Inagen; Infectious Disease; InfectiousDisease; Islt; Isol; Myambutol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutol; Olbutam; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis |
2.27 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 55155-6 |
Flunitrazepam & 7-Aminoflunitrazepam panel |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Flunitrazepam and 7-Aminoflunitrazepam panel [Mass/volume] - Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
55155-6 |
|
|
|
|
Order |
|
|
|
0 |
Flunitrazepam+7Amino Pnl Ur-mCnc |
|
|
|
N |
|
7-amino flunitrazepam; 7Aminoflunitrazepam; Darkene; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; Flunitrazepam+7Amino Pnl; Hypnodorm; Hypnor; Level; Mass concentration; Narcozep; Noriel; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Rohipnol; Rohypnol; Roipnol; UA; UR; Urn; Valsera |
2.48 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55156-4 |
Minocycline |
Susc |
Isolate |
Pt |
OrdQn |
Method for Slow-growing mycobacteria |
|
ACTIVE |
Minocycline [Susceptibility] by Method for Slow-growing mycobacteria |
|
MIN |
DefinitionDescription |
|
|
|
Susceptible, Resistant, Indeterminate |
|
|
|
|
|
ABXBACT |
|
55156-4 |
|
Method for Slow-growing mycobacteria |
|
|
Observation |
|
|
|
0 |
Minocycline Islt SlowMyco |
|
|
|
N |
|
AFB; Aknemin; ANTIBIOTIC SUSCEPTIBILITIES; AST; c128; Dentomycin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klinomysin; Lederderm; Mestacine; Mino-50; Minocin; Minomycin; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mynocine; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis |
2.27 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 55157-2 |
Risperidone & 9-Hydroxyrisperidone panel |
- |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
risperiDONE and 9-Hydroxyrisperidone panel - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
55157-2 |
|
|
|
|
Order |
|
|
|
0 |
risperiDONE+9OH-Ris Pnl SerPl |
|
|
|
N |
|
9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; DRUG/TOXICOLOGY; Drugs; Invega; Paliperidone; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Risperidal; Risperidone metabolite; risperiDONE+9OH-Ris; risperiDONE+9OH-Ris Pnl; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55158-0 |
Tigecycline |
Susc |
Isolate |
Pt |
OrdQn |
Method for Slow-growing mycobacteria |
|
ACTIVE |
Tigecycline [Susceptibility] by Method for Slow-growing mycobacteria |
|
MIN |
DefinitionDescription |
|
|
|
Susceptible, Indeterminate, Resistant |
|
|
|
|
|
ABXBACT |
|
55158-0 |
|
Method for Slow-growing mycobacteria |
|
|
Observation |
|
|
|
0 |
Tigecycline Islt SlowMyco |
|
|
|
N |
|
AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; Tygacil; Tygecycline |
2.27 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 55159-8 |
Ursodeoxycholate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ursodeoxycholate [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/l |
|
|
|
|
|
|
CHEM |
|
55159-8 |
|
|
|
|
Both |
|
|
|
0 |
Ursodeoxycholate SerPl-sCnc |
|
|
|
N |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UDC; UDCA; Ursodeoxycholic acid; Ursodiol |
2.73 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
Release 2.67: SYSTEM: Added Plas because this test can be run on both serum and plasma |
0 |
| 5516-0 |
CD66a |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD66a cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5516-0 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD66a WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; BGP; Biliary glycoprotein; CELL MARKERS; Leukocytes; NCA-160; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 55160-6 |
Adenovirus Ab.IgG & IgM panel |
- |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Adenovirus IgG and IgM panel - Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
55160-6 |
|
|
|
|
Order |
|
|
|
0 |
HAdV IgG+IgM Pnl Ser |
|
|
|
N |
|
Adeno virus; HAdV; HAdV IgG+IgM Pnl; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders |
2.7 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55161-4 |
Bordetella pertussis Ab.IgA & IgG panel |
- |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Bordetella pertussis IgA and IgG panel - Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
55161-4 |
|
IA |
|
|
Order |
|
|
|
0 |
B pert IgA+IgG Pnl Ser IA |
|
|
|
N |
|
B pert; B pert IgA+IgG Pnl; B pertussis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pertussis; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; Whooping cough |
2.73 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 55162-2 |
HTLV I+II Ab panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
HTLV I+II Ab panel - Serum |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
55162-2 |
|
|
|
|
Order |
|
|
|
0 |
HTLV I+II Ab Pnl Ser |
|
|
|
N |
|
2; HTLV I+II Ab Pnl; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR |
2.7 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.70: SCALE_TYP: Enable use of this panel for a broader set of local panels.; |
0 |
| 55163-0 |
Streptococcus pyogenes enzyme Ab panel |
- |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Streptococcus pyogenes enzyme Ab panel - Serum Qualitative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
55163-0 |
|
|
|
|
Order |
|
|
|
0 |
S pyog enzyme Ab Pnl Ser |
|
|
|
N |
|
Enz; Enzymes; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; S pyog enzyme Ab Pnl; S pyog.enz; S pyogenes; Screen; Serum; SR; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; Streptozyme |
2.42 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55164-8 |
Paroxysmal nocturnal panel |
- |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Paroxysmal nocturnal panel - Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CELLMARK |
|
55164-8 |
|
|
|
|
Order |
|
|
|
0 |
Paroxysmal nocturnal Pnl Bld |
|
|
|
N |
|
Blood; CELL MARKERS; Pan; PANEL.CELLMARK; Panl; Paroxysmal nocturnal Pnl; PNH; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood |
2.73 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55165-5 |
Echinococcus sp Ab.IgG4 |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Echinococcus sp IgG4 Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
55165-5 |
|
|
|
|
Both |
|
|
|
0 |
Echinococcus IgG4 Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Echinococcosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; p2; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR |
2.7 |
2.27 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 55166-3 |
Hepatitis G virus E2 Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Hepatitis G virus E2 Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
55166-3 |
|
|
|
|
Both |
|
|
|
0 |
HGV E2 Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hep; Hep G; Hepatis; Hepatit; HGV; HGV E2; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.7 |
2.27 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 55167-1 |
Mycoplasma sp Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Mycoplasma sp Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
55167-1 |
|
|
|
|
Both |
|
|
|
0 |
Mycoplasma Ab CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp |
2.7 |
2.27 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 55168-9 |
Data Elements for Emergency Department Systems (DEEDS) Release 1.1 |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Data Elements for Emergency Department Systems (DEEDS) Release 1.1 |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ED |
|
55168-9 |
|
|
|
|
|
|
|
|
0 |
DEEDS 1.1 |
|
|
|
N |
|
DEEDS; DEEDS 1.1; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random |
2.73 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55169-7 |
Data Elements for Emergency Department Systems (DEEDS) Release 1.0 |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Data Elements for Emergency Department Systems (DEEDS) Release 1.0 |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ED |
|
55169-7 |
|
|
|
|
|
|
|
|
0 |
DEEDS 1.0 |
|
|
|
N |
|
DEEDS; DEEDS 1.0; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random |
2.27 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 5517-8 |
CD66b |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD66b cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5517-8 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD66b WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; CD67; CELL MARKERS; CGM6; Leukocytes; NCA-95; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 55170-5 |
Cytoplasmic Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Cytoplasmic Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
Cytoplasmic antibody titer: 1:320. |
|
|
|
|
|
SERO |
|
55170-5 |
|
IF |
|
|
Both |
|
|
|
0 |
Cytoplasmic Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.27 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 55171-3 |
Cytoplasmic Ab pattern |
Imp |
Ser |
Pt |
Nom |
IF |
|
ACTIVE |
Cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
Cytoplasmic antibody pattern: PL7/PL12-like. |
|
|
|
|
|
SERO |
|
55171-3 |
|
IF |
|
|
Both |
|
|
|
0 |
Cytoplasmic Ab pattern Ser IF-Imp |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CA Pat; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 55172-1 |
ED procedures and results |
- |
^Patient |
Pt |
Set |
DEEDS |
|
ACTIVE |
ED procedures and results Set DEEDS |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ED |
|
55172-1 |
|
DEEDS |
|
|
|
|
|
|
0 |
ED procedures & results DEEDS |
|
|
|
N |
|
Data Elements for Emergency Department Systems; DEEDS; ED procedures & results; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random |
2.79 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55173-9 |
ED disposition and diagnosis data |
- |
^Patient |
Pt |
Set |
DEEDS |
|
ACTIVE |
ED disposition and diagnosis data Set DEEDS |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ED |
|
55173-9 |
|
DEEDS |
|
|
|
|
|
|
0 |
ED dispo & Dx data DEEDS |
|
|
|
N |
|
Data Elements for Emergency Department Systems; DEEDS; Dx; ED dispo & Dx data; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random |
2.27 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55174-7 |
Patient identification data |
- |
^Patient |
Pt |
Set |
DEEDS |
|
ACTIVE |
Patient identification data Set DEEDS |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ED |
|
55174-7 |
|
DEEDS |
|
|
|
|
|
|
0 |
Patient ID data DEEDS |
|
|
|
N |
|
Data Elements for Emergency Department Systems; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Patient ID data; Pnl; Point in time; Random |
2.73 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 55175-4 |
Facility and Practitioner identification data |
- |
^Patient |
Pt |
Set |
DEEDS |
|
ACTIVE |
Facility and Practitioner identification data Set DEEDS |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ED |
|
55175-4 |
|
DEEDS |
|
|
|
|
|
|
0 |
Facility & Practitioner ID data DEEDS |
|
|
|
N |
|
Data Elements for Emergency Department Systems; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Facility & Practitioner ID data; Pan; Panel; Panl; Pnl; Point in time; Random |
2.27 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
